R&D Suitability

By choosing Eurotrials as your partner you can benefit from tax incentives.

With the agreement between APIFARMA and the Portuguese Government, you can deduct from your contribution the expenses with R&D services, when contracted from a suitable recognized company.

Since 2013 Eurotrials is recognized by the Portuguese Government for its suitability in the areas of process development and R&D projects. According to SIFIDE  (the Portuguese System of Tax Incentives for Business Research and Development), and the Tax Agreement between the Pharmaceutical Companies and the Portuguese Government, all R&D services contracted with Eurotrials are eligible for the tax incentive associated with SIFIDE, or can be used to offset the tax payments associated with the above mentioned agreement.

This agreement was stablished to achieve the budget goals for 2017, where the Industry accepts to contribute to the public expenses control with a contribution of 200 million euros.

All the expenses with research and development* can be deducted from this contribution, as the Portuguese Government pretends to promote innovation and market access to innovative therapies, then creating a favorable environment for investment, R&D and healthcare advancement.

Type of Studies

Clinical Trials

Phase I, II, II, IV

Late Phase

Post Approval Effectiveness Studies

Post Approval Safety Studies

Post Marketing Observational

Health Economic and Outcome Research


Population / Disease Characterization

Clinical Practice Characterization

Disease Registry

Health Behavior Studies

Prevalence / Incidence

Product Registry

Validation Studies

Type of Services



Cell Therapy products

Gene therapy products

Herbal products

Homeopathic products

Medical Devices

Other extractive products

Plasma derived products

Radiopharmaceutical products

Small molecule

Type of Products

R&D Consultancy

Clinical Research Methodology Consultancy

Feasibility Analysis

Study Design

Translational Research Studies

Implementation and Monitoring of Clinical Trials

Remote Monitoring & Risk-Based Monitoring

Observational Studies Design and Implementation

Data Management

Consultancy in Biostatistics

Medical Writing

Strategy & Regulatory Requirements Consultancy

Cosmetics, Functional Foods and Medical Devices


Health Economics


Teaching & Training

SIFIDE is the Portuguese System of Tax Incentives for Business R&D, which aims to improve Portuguese companies’ competitiviness by allowing the dediction of the respective expenses from the IRC tax collection.

Since 2011 SIFIDE II is operative, with the introduction of some legislation alterations, becoming more attractive to the companies.

Find out more by clicking in the image on the right.